1-hydroxyanthraquinone has been researched along with indomethacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, T; Mori, H; Sugie, S; Tanaka, T; Yoshimi, N | 1 |
| Kojima, T; Mori, H; Okamoto, K; Suzui, M; Tanaka, T; Wang, A | 1 |
2 other study(ies) available for 1-hydroxyanthraquinone and indomethacin
| Article | Year |
|---|---|
Inhibitory effect of the non-steroidal anti-inflammatory drug, indomethacin on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male ACI/N rats.
Topics: Adenocarcinoma; Animals; Anthraquinones; Carcinoma, Squamous Cell; Colonic Neoplasms; Enterocolitis; Epithelium; Indomethacin; Liver; Male; Papilloma; Precancerous Conditions; Rats; Rats, Inbred ACI; Stomach Neoplasms | 1991 |
Chemoprevention of the naturally occurring carcinogen 1-hydroxyanthraquinone-induced carcinogenesis by the nonsteroidal anti-inflammatory drug indomethacin in rats.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Carcinogens; Gastrointestinal Neoplasms; Indomethacin; Male; Ornithine Decarboxylase Inhibitors; Rats; Rats, Inbred ACI | 1995 |